
Opinion|Videos|December 23, 2024
NCQA Guidelines and the KDIGO Heat Map in CKD Management
Key Takeaways
- Identifying at-risk patients for CKD in Type 2 Diabetes involves assessing hypertension, family history, and blood glucose levels.
- Screening tests for CKD include eGFR and UACR, essential for early detection in diabetic patients.
Panelists discuss how NCQA guidelines apply to chronic kidney disease (CKD) management and the role of the KDIGO heat map in enhancing clinical practice.
Advertisement
- How do NCQA guidelines apply to CKD management, and what is the KDIGO heat map's role in clinical practice?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on HCPLive
1
VIASKIN Peanut Patch Efficacy Holds in Kids With Atopic Comorbidities
2
Fezolinetant Shows No CNS Safety Signal in Pooled Analysis of 3100 Women, With Marla Shapiro, CM
3
CAPTAIN-T2D: Interim Results Display High Cortisol Prevalence in Difficult-to-Control T2D
4
Rethinking “Type 2”: Inside the 2026 AACE Diabetes Classification Algorithm
5
























































